SARS News and Research

RSS

Potency of neutralizing antibodies predicts COVID-19 severity and survival

Understanding the body's immune response to SARS-CoV-2, the virus that causes COVID-19, is key to developing effective treatments and long-lasting vaccines.

16 Dec 2020

Research reveals two phases of infection in patients with severe COVID-19 pneumonia

What does SARS-CoV-2, the virus that causes COVID-19, do once it enters a person's airways, and how does infection in lung cells affect patients' immune responses?

16 Dec 2020

FDA issues new emergency use authorization for BinaxNOW COVID-19 Ag Card Home Test

Today, the U.S. Food and Drug Administration issued a new emergency use authorization (EUA) for the BinaxNOW COVID-19 Ag Card Home Test which is authorized for use by patients at home with a prescription.

16 Dec 2020

Mass testing is not a ‘silver bullet’ for managing SARS-CoV-2 transmission, say researchers

A team of researchers from various institutions in France recently used a mathematical model to assess the impact of mass testing in controlling the SARS-CoV-2 epidemic. They evaluated the potential impact of mass testing campaigns in an epidemic rebound scenario at the end of the ongoing lockdown in Metropolitan France.

16 Dec 2020

Traditional herbal medicine Respiratory Detox Shot (RDS) inhibits SARS-CoV, SARS-CoV-2 and Influenza A infection in vitro

As researchers continue to search for antivirals to counter COVID-19, a study presents the potential utility of a decoction called Respiratory Detox Shot (RDS).

16 Dec 2020

Azithromycin trial fails to provide evidence of benefit in COVID-19

Early on in the COVID-19 pandemic, azithromycin was regarded as being a potentially highly effective drug against the virus that causes it, SARS-CoV-2.

16 Dec 2020

Survey suggests COVID-19 vaccine hesitancy stems from a distrust in the vaccine development and approval process

Survey results of COVID-19 vaccine hesitancy suggest that people are less likely to get the COVID-19 vaccine than the number of people who got the flu shot.

16 Dec 2020

Copper gluconate supplementation could reduce SARS-CoV-2 infection in vitro

The second wave of COVID-19 has affected many countries, costing thousands of lives and dealing further heavy blows to already reeling economies.

16 Dec 2020

Autoimmune condition biomarkers promote SARS-CoV-2 viral entry, study finds

Researchers have reported that the autoimmune PTPN2 risk variant rs1893217 promotes the expression of the SARS-CoV-2 receptor, ACE2, and thus promotes cellular entry, which is mediated by SARS-CoV-2 spike S protein.

16 Dec 2020

SARS-CoV-2 RNA can be reverse-transcribed to be part of chimeric viral-human genome

A new study reveals that the genome of SARS-CoV-2 is inserted into the human genome, accounting for the detection of viral RNAs.

16 Dec 2020

Methylene blue and light inactivates SARS-CoV-2 on N95 respirators and masks, study finds

Researchers at the University of Washington show that methylene blue (MB) and light can decontaminate masks and respirators by inactivating three tested coronaviruses without compromising integrity. The method is effective, low-cost, and does not require specialized equipment, making it applicable in any setting.

16 Dec 2020

Clearer information and increased support may improve compliance with COVID-19 guidelines, says study

UK-based researchers have found that providing clear information and practical or financial support could reduce the number of people who feel that they have to break lockdown rules. They have also evaluated the risk tied to engaging in a particular behavior.

16 Dec 2020

CN Bio and the University of Melbourne collaborate to advance therapies for respiratory complications in recovered COVID-19 patients

CN Bio, a leading cell culture company, that has developed single and multi-organ microphysiological systems (MPS) to improve the accuracy and efficiency of drug discovery, today announced a collaboration with the University of Melbourne, focused on respiratory therapies for recovering COVID-19 patients.

From AXT Pty Ltd 16 Dec 2020

RedHill Biopharma announces promising preliminary results from opaganib study

TEL AVIV, Israel and RALEIGH, NC, December 15, 2020, RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced promising preliminary results from a preclinical study with opaganib.

15 Dec 2020

New modeling study identifies effective nonpharmaceutical interventions at reducing COVID-19 transmission

Limiting gatherings to fewer than 10 people and closing educational institutions were among the most effective nonpharmaceutical interventions at reducing transmission of SARS-CoV-2, a new modeling study finds.

15 Dec 2020

SARS-CoV-2 unique deletion variants found in clinical specimens

While participating in the SPHERES Consortium project, US researchers sequenced 2,726 clinical patient specimens gathered in March 2020 and identified eight unique ORF7a deletion variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Their results are currently available on the bioRxiv* preprint server.

15 Dec 2020

Neanderthal gene variant increases risk of severe COVID-19

Researchers in Germany have conducted a study showing that between 2 and 8% of people in Eurasia carry a genetic variant inherited from Neanderthals that significantly increases the risk of becoming critically ill with coronavirus disease 2019 (COVID-19).

15 Dec 2020

SARS News and Research

Potency of neutralizing antibodies predicts COVID-19 severity and survival

Research reveals two phases of infection in patients with severe COVID-19 pneumonia

FDA issues new emergency use authorization for BinaxNOW COVID-19 Ag Card Home Test

Mass testing is not a ‘silver bullet’ for managing SARS-CoV-2 transmission, say researchers

Traditional herbal medicine Respiratory Detox Shot (RDS) inhibits SARS-CoV, SARS-CoV-2 and Influenza A infection in vitro

Azithromycin trial fails to provide evidence of benefit in COVID-19

Survey suggests COVID-19 vaccine hesitancy stems from a distrust in the vaccine development and approval process

Copper gluconate supplementation could reduce SARS-CoV-2 infection in vitro

Autoimmune condition biomarkers promote SARS-CoV-2 viral entry, study finds

SARS-CoV-2 RNA can be reverse-transcribed to be part of chimeric viral-human genome

Methylene blue and light inactivates SARS-CoV-2 on N95 respirators and masks, study finds

Clearer information and increased support may improve compliance with COVID-19 guidelines, says study

CN Bio and the University of Melbourne collaborate to advance therapies for respiratory complications in recovered COVID-19 patients

RedHill Biopharma announces promising preliminary results from opaganib study

New modeling study identifies effective nonpharmaceutical interventions at reducing COVID-19 transmission

SARS-CoV-2 unique deletion variants found in clinical specimens

Neanderthal gene variant increases risk of severe COVID-19

AI-based study of social media maps SARS-CoV-2 vaccine hesitancy across the US

Could wastewater surveillance help track SARS-COV-2 community outbreaks?

Telemedicine needed to diagnose and treat swallowing difficulties in COVID-19 patients, say physicians

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News